These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25088224)

  • 1. The S1P1 receptor-selective agonist CYM-5442 reduces the severity of acute GVHD by inhibiting macrophage recruitment.
    Cheng Q; Ma S; Lin D; Mei Y; Gong H; Lei L; Chen Y; Zhao Y; Hu B; Wu Y; Yu X; Zhao L; Liu H
    Cell Mol Immunol; 2015 Nov; 12(6):681-91. PubMed ID: 25088224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.
    Gonzalez-Cabrera PJ; Jo E; Sanna MG; Brown S; Leaf N; Marsolais D; Schaeffer MT; Chapman J; Cameron M; Guerrero M; Roberts E; Rosen H
    Mol Pharmacol; 2008 Nov; 74(5):1308-18. PubMed ID: 18708635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate receptor-1 (S1P
    Karuppuchamy T; Behrens EH; González-Cabrera P; Sarkisyan G; Gima L; Boyer JD; Bamias G; Jedlicka P; Veny M; Clark D; Peach R; Scott F; Rosen H; Rivera-Nieves J
    Mucosal Immunol; 2017 Jan; 10(1):162-171. PubMed ID: 27049060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S1P(1) receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis.
    Gonzalez-Cabrera PJ; Cahalan SM; Nguyen N; Sarkisyan G; Leaf NB; Cameron MD; Kago T; Rosen H
    Mol Pharmacol; 2012 Feb; 81(2):166-74. PubMed ID: 22031473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.
    Scott FL; Clemons B; Brooks J; Brahmachary E; Powell R; Dedman H; Desale HG; Timony GA; Martinborough E; Rosen H; Roberts E; Boehm MF; Peach RJ
    Br J Pharmacol; 2016 Jun; 173(11):1778-92. PubMed ID: 26990079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between the anti-allodynic effects of fingolimod (FTY720) and desensitization of S1P
    Pondelick AM; Moncayo LV; Donvito G; McLane VD; Gillespie JC; Hauser KF; Spiegel S; Lichtman AH; Sim-Selley LJ; Selley DE
    Neuropharmacology; 2024 Dec; 261():110165. PubMed ID: 39303855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation.
    Zhang Y; McCormick LL; Desai SR; Wu C; Gilliam AC
    J Immunol; 2002 Mar; 168(6):3088-98. PubMed ID: 11884483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
    Li C; Li JN; Kays J; Guerrero M; Nicol GD
    J Neuroinflammation; 2015 Apr; 12():70. PubMed ID: 25880547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss.
    Blanco R; Martínez-Navarrete G; Valiente-Soriano FJ; Avilés-Trigueros M; Pérez-Rico C; Serrano-Puebla A; Boya P; Fernández E; Vidal-Sanz M; de la Villa P
    Exp Eye Res; 2017 Nov; 164():37-45. PubMed ID: 28827028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3.
    Maeda Y; Matsuyuki H; Shimano K; Kataoka H; Sugahara K; Chiba K
    J Immunol; 2007 Mar; 178(6):3437-46. PubMed ID: 17339438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease.
    Fulton LM; Taylor NA; Coghill JM; West ML; Föger N; Bear JE; Baldwin AS; Panoskaltsis-Mortari A; Serody JS
    Eur J Immunol; 2014 Jun; 44(6):1662-71. PubMed ID: 24752751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes.
    Singer II; Tian M; Wickham LA; Lin J; Matheravidathu SS; Forrest MJ; Mandala S; Quackenbush EJ
    J Immunol; 2005 Dec; 175(11):7151-61. PubMed ID: 16301618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
    Mullershausen F; Craveiro LM; Shin Y; Cortes-Cros M; Bassilana F; Osinde M; Wishart WL; Guerini D; Thallmair M; Schwab ME; Sivasankaran R; Seuwen K; Dev KK
    J Neurochem; 2007 Aug; 102(4):1151-61. PubMed ID: 17488279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
    J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
    Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
    Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist.
    Gao M; Liu Y; Xiao Y; Han G; Jia L; Wang L; Lei T; Huang Y
    PLoS One; 2014; 9(9):e105693. PubMed ID: 25216235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sphingosine-1-phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration.
    Yamamoto R; Aoki T; Koseki H; Fukuda M; Hirose J; Tsuji K; Takizawa K; Nakamura S; Miyata H; Hamakawa N; Kasuya H; Nozaki K; Hirayama Y; Aramori I; Narumiya S
    Br J Pharmacol; 2017 Jul; 174(13):2085-2101. PubMed ID: 28409823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection.
    St John AL; Ang WXG; Huang MN; Kunder CA; Chan EW; Gunn MD; Abraham SN
    Immunity; 2014 Sep; 41(3):440-450. PubMed ID: 25238098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.